Gelb, Arthur F., M.D.
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Gelb, Arthur F., M.D. sits in the upper quartile of US sponsors by registered trial count (#1,806 of 15,742 sponsors by registered trial count).
Gelb, Arthur F., M.D.: 7 sponsored US clinical trials, 4 recruiting.
Gelb, Arthur F., M.D. sponsors 7 registered US clinical trials on ClinicalTrials.gov, 4 of them currently recruiting, and 3 completed. 3 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Asthma, with 2 trials.
Upper-quartile sponsor footprint
Gelb, Arthur F., M.D. sits in the upper quartile of the sponsor corpus (#1,806 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
7 total, page 1 of 1
Detection of Unsuspected Small Airways Obstruction in Cystic Fibrosis
NCT03839992
Site and Mechanism(s) of Expiratory Airflow Limitation in COPD, Emphysema and Asthma-COPD Overlap
NCT03263130
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
NCT00576069
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
NCT01225913
Dynamic Hyperinflation and Tiotropium
NCT00569270
Zileuton and Exhaled Nitric Oxide in Asthmatics
NCT00575861
Tiotropium Induced Bronchodilation in Lung CT Scored Emphysema
NCT00570544
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 3 |
Therapeutic Areas
Where Gelb, Arthur F., M.D. enrollment is open (later-stage tilt)
4 recruiting of 7 indexed (57% open); 3 completed (43%).
Phase mix: 3 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Asthma (2 trials), 3 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Gelb, Arthur F., M.D.: open-pipeline peers nationwide
Peers matched on 7 registered trials and 57% open enrollment, not the therapeutic-area sidebar.
Gelb, Arthur F., M.D. sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 7 trials (± recruiting share)
- 3M · 7 trials · 0% recruiting
- 4Life Research · 7 trials · 0% recruiting
- 89bio · 7 trials · 29% recruiting
- Abbott Diagnostics Division · 7 trials · 0% recruiting
Sponsors near 57% open enrollment (± trial volume)
- Alimentiv · 57% recruiting · 7 trials
- Aura Biosciences · 57% recruiting · 7 trials
- BicycleTx Limited · 57% recruiting · 7 trials
- Binghamton University · 57% recruiting · 7 trials
Related
What to do with this Gelb, Arthur F., M.D. page
7 registered trials is a research-attention snapshot, not an endorsement of Gelb, Arthur F., M.D. or any single study.
- 4 of Gelb, Arthur F., M.D.'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Asthma is the condition Gelb, Arthur F., M.D. studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Asthma trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Gelb, Arthur F., M.D. pipeline card: 7 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.